• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Boosting immunity to COVID-19 vaccines.

作者信息

Juno Jennifer A, Wheatley Adam K

机构信息

Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

出版信息

Nat Med. 2021 Nov;27(11):1874-1875. doi: 10.1038/s41591-021-01560-x.

DOI:10.1038/s41591-021-01560-x
PMID:34764485
Abstract
摘要

相似文献

1
Boosting immunity to COVID-19 vaccines.增强对新冠疫苗的免疫力。
Nat Med. 2021 Nov;27(11):1874-1875. doi: 10.1038/s41591-021-01560-x.
2
The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses.反对延迟严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗加强针接种的理由
Clin Infect Dis. 2021 Oct 5;73(7):1321-1323. doi: 10.1093/cid/ciab070.
3
Mix-and-match COVID vaccines trigger potent immune response.混合搭配新冠疫苗引发强烈免疫反应。
Nature. 2021 May;593(7860):491. doi: 10.1038/d41586-021-01359-3.
4
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
5
Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.作者回应：新冠病毒疫苗对严重急性呼吸综合征冠状病毒2感染的有效性和效果：关于无症状严重急性呼吸综合征冠状病毒2感染的更多数据
Euro Surveill. 2021 Sep;26(35). doi: 10.2807/1560-7917.ES.2021.26.35.2100832.
6
Covid-19 vaccines, immunity, and boosters.新冠病毒疫苗、免疫力与加强针
BMJ. 2021 Dec 20;375:n3105. doi: 10.1136/bmj.n3105.
7
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
8
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
9
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.新冠病毒感染后与 SARS-CoV-2 疫苗接种的感染后免疫
Viral Immunol. 2021 Oct;34(8):504-509. doi: 10.1089/vim.2021.0054. Epub 2021 Jul 5.
10
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.黏膜疫苗对恒河猴感染 SARS-CoV-2 的保护作用。
JCI Insight. 2021 Apr 28;6(10):148494. doi: 10.1172/jci.insight.148494.

引用本文的文献

1
Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan.台湾地区接种疫苗的医护人员体内针对新冠病毒的中和抗体
Ann Med. 2025 Dec;57(1):2442533. doi: 10.1080/07853890.2024.2442533. Epub 2024 Dec 23.
2
The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol.《COVID-19 疫苗初级和加强（PICOBOO）加强接种亚研究方案》平台试验。
Trials. 2024 Nov 1;25(1):735. doi: 10.1186/s13063-024-08456-4.
3
Liver function abnormality on admission predicts long COVID syndrome in digestive system.

本文引用的文献

1
Waning Immunity after the BNT162b2 Vaccine in Israel.以色列接种 BNT162b2 疫苗后的免疫力下降。
N Engl J Med. 2021 Dec 9;385(24):e85. doi: 10.1056/NEJMoa2114228. Epub 2021 Oct 27.
2
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.成年人实体瘤中接受两剂和三剂 BNT162b2 mRNA 疫苗的免疫反应。
Nat Med. 2021 Nov;27(11):2002-2011. doi: 10.1038/s41591-021-01542-z. Epub 2021 Sep 30.
3
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.AZD1222（ChAdOx1 nCoV-19）新冠疫苗的 3 期安全性和疗效。
入院时肝功能异常可预测消化系统的长期新冠综合征。
Heliyon. 2024 Sep 12;10(19):e37664. doi: 10.1016/j.heliyon.2024.e37664. eCollection 2024 Oct 15.
4
Cytokine profile of anti-spike CD4T cells predicts humoral and CD8T cell responses after anti-SARS-CoV-2 mRNA vaccination.抗刺突蛋白CD4 T细胞的细胞因子谱可预测抗SARS-CoV-2 mRNA疫苗接种后的体液和CD8 T细胞反应。
iScience. 2024 Jul 2;27(8):110441. doi: 10.1016/j.isci.2024.110441. eCollection 2024 Aug 16.
5
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers.医护人员中 BNT162b2 和科兴疫苗的有效性及加强针。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2275445. doi: 10.1080/21645515.2023.2275445. Epub 2023 Nov 15.
6
Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine.性别和年龄对加强型 mRNA COVID-19 疫苗相关副作用及其进展的影响。
Sci Rep. 2023 Nov 7;13(1):19328. doi: 10.1038/s41598-023-46823-4.
7
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.科兴新冠疫苗同源加强针在60岁及以上老年人中的免疫原性和安全性：一项接种间隔研究 - 中国云南省，2021 - 2022年
China CDC Wkly. 2023 Feb 10;5(6):125-130. doi: 10.46234/ccdcw2023.023.
8
Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants.新冠病毒刺突蛋白与三个关键伙伴的分子识别：探索病毒突变体可能的免疫逃逸机制。
J Mol Model. 2023 Mar 24;29(4):109. doi: 10.1007/s00894-023-05509-4.
9
Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice.三价严重急性呼吸综合征冠状病毒2刺突蛋白S1亚基疫苗接种在BALB/c小鼠中诱导广泛的体液免疫反应。
Vaccines (Basel). 2023 Jan 31;11(2):314. doi: 10.3390/vaccines11020314.
10
Loss-framing of information and pre-vaccination consultation improve COVID-19 vaccine acceptance: A survey experiment.信息损失框架和疫苗接种前咨询可提高 COVID-19 疫苗接种接受率：一项调查实验。
Front Public Health. 2023 Jan 24;11:1063444. doi: 10.3389/fpubh.2023.1063444. eCollection 2023.
N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29.
4
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.在健康成年人中，SARS-CoV-2 变异 mRNA 疫苗加强针的安全性和免疫原性：一项中期分析。
Nat Med. 2021 Nov;27(11):2025-2031. doi: 10.1038/s41591-021-01527-y. Epub 2021 Sep 15.
5
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.COVID-19 严重程度与抗体 Fc 介导的固有免疫功能的差异有关。
mBio. 2021 Apr 20;12(2):e00281-21. doi: 10.1128/mBio.00281-21.